This bill became law
What it doesSummary public law (Oct 10, 2018)
Know the Lowest Price Act of 2018
(Sec. 2) This bill prohibits a prescription drug plan under Medicare or Medicare Advantage from restricting a pharmacy from informing an enrollee of any difference between the price, copayment, or coinsurance of a drug under the plan and a lower price of the drug without health-insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
What just happenedOct 10, 2018
Became Public Law No: 115-262.
Who’s behind it
Became Public Law No: 115-262.
Became Public Law No: 115-262.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Correct Enrollment
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H8799)
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H8799)
DEBATE - The House proceeded with forty minutes of debate on S. 2553.
Considered under suspension of the rules. (consideration: CR H8799-8801)
Mr. Burgess moved to suspend the rules and pass the bill.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Received in the House.
Message on Senate action sent to the House.
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (text: CR S6033)
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.(text: CR S6033)
Measure laid before Senate by unanimous consent. (consideration: CR S6033)
Senate Committee on Finance discharged by Unanimous Consent.
Senate Committee on Finance discharged by Unanimous Consent.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Know the Lowest Price Act of 2018
(Sec. 2) This bill prohibits a prescription drug plan under Medicare or Medicare Advantage from restricting a pharmacy from informing an enrollee of any difference between the price, copayment, or coinsurance of a drug under the plan and a lower price of the drug without health-insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
Know the Lowest Price Act of 2018
(Sec. 2) This bill prohibits a prescription drug plan under Medicare or Medicare Advantage from restricting a pharmacy from informing an enrollee of any difference between the price, copayment, or coinsurance of a drug under the plan and a lower price of the drug without health-insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
Know the Lowest Price Act of 2018
(Sec. 2) This bill prohibits a prescription drug plan under Medicare or Medicare Advantage from restricting a pharmacy from informing an enrollee of any difference between the price, copayment, or coinsurance of a drug under the plan and a lower price of the drug without health-insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
Know the Lowest Price Act of 2018
This bill prohibits a health-benefits plan or pharmacy-benefits manager under Medicare or Medicare Advantage from restricting a pharmacy from informing an enrollee of any difference between the price of a drug under the plan and the price of the drug without health-insurance coverage.